These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 20060728)

  • 1. Synthesis and optimization of hyaluronic acid-methotrexate conjugates to maximize benefit in the treatment of osteoarthritis.
    Homma A; Sato H; Tamura T; Okamachi A; Emura T; Ishizawa T; Kato T; Matsuura T; Sato S; Higuchi Y; Watanabe T; Kitamura H; Asanuma K; Yamazaki T; Ikemi M; Kitagawa H; Morikawa T; Ikeya H; Maeda K; Takahashi K; Nohmi K; Izutani N; Kanda M; Suzuki R
    Bioorg Med Chem; 2010 Feb; 18(3):1062-75. PubMed ID: 20060728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel hyaluronic acid-methotrexate conjugate suppresses joint inflammation in the rat knee: efficacy and safety evaluation in two rat arthritis models.
    Tamura T; Higuchi Y; Kitamura H; Murao N; Saitoh R; Morikawa T; Sato H
    Arthritis Res Ther; 2016 Apr; 18():79. PubMed ID: 27039182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel hyaluronic acid-methotrexate conjugates for osteoarthritis treatment.
    Homma A; Sato H; Okamachi A; Emura T; Ishizawa T; Kato T; Matsuura T; Sato S; Tamura T; Higuchi Y; Watanabe T; Kitamura H; Asanuma K; Yamazaki T; Ikemi M; Kitagawa H; Morikawa T; Ikeya H; Maeda K; Takahashi K; Nohmi K; Izutani N; Kanda M; Suzuki R
    Bioorg Med Chem; 2009 Jul; 17(13):4647-56. PubMed ID: 19457673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel oxido-viscosifying Hyaluronic Acid-antioxidant conjugate for osteoarthritis therapy: biocompatibility assessments.
    Kaderli S; Boulocher C; Pillet E; Watrelot-Virieux D; Roger T; Viguier E; Gurny R; Scapozza L; Möller M
    Eur J Pharm Biopharm; 2015 Feb; 90():70-9. PubMed ID: 25445302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A hyaluronic acid-salmon calcitonin conjugate for the local treatment of osteoarthritis: chondro-protective effect in a rabbit model of early OA.
    Mero A; Campisi M; Favero M; Barbera C; Secchieri C; Dayer JM; Goldring MB; Goldring SR; Pasut G
    J Control Release; 2014 Aug; 187():30-8. PubMed ID: 24837189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High molecular weight hyaluronic acid down-regulates the gene expression of osteoarthritis-associated cytokines and enzymes in fibroblast-like synoviocytes from patients with early osteoarthritis.
    Wang CT; Lin YT; Chiang BL; Lin YH; Hou SM
    Osteoarthritis Cartilage; 2006 Dec; 14(12):1237-47. PubMed ID: 16806998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor properties and toxicity of dextran-methotrexate conjugates are dependent on the molecular weight of the carrier.
    Nevozhay D; Budzynska R; Kanska U; Jagiello M; Omar MS; Boratynski J; Opolski A
    Anticancer Res; 2006; 26(2A):1135-43. PubMed ID: 16619515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic effect of intra-articular injection of high molecular weight hyaluronic acid on osteoarthritis of the knee.
    Namiki O; Toyoshima H; Morisaki N
    Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):501-7. PubMed ID: 7174151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Hylan G-F 20 for viscosupplementation of the temporomandibular joint for the management of osteoarthritis: a case report.
    Yustin D; Kryshtalskyj B; Galea A
    J Orofac Pain; 1995; 9(4):375-9. PubMed ID: 8995909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyaluronic Acid-Based Dissolving Microneedle Patch Loaded with Methotrexate for Improved Treatment of Psoriasis.
    Du H; Liu P; Zhu J; Lan J; Li Y; Zhang L; Zhu J; Tao J
    ACS Appl Mater Interfaces; 2019 Nov; 11(46):43588-43598. PubMed ID: 31651148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The molecular weight of therapeutic hyaluronan (sodium hyaluronate): how significant is it?
    Aviad AD; Houpt JB
    J Rheumatol; 1994 Feb; 21(2):297-301. PubMed ID: 8182640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth inhibition, drug load, and degradation studies of gelatin/methotrexate conjugates.
    Ofner CM; Pica K; Bowman BJ; Chen CS
    Int J Pharm; 2006 Feb; 308(1-2):90-9. PubMed ID: 16361072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy study of two novel hyaluronic acid-based formulations for viscosupplementation therapy in an early osteoarthrosic rabbit model.
    Kaderli S; Viguier E; Watrelot-Virieux D; Roger T; Gurny R; Scapozza L; Möller M; Boulocher C; Jordan O
    Eur J Pharm Biopharm; 2015 Oct; 96():388-95. PubMed ID: 26369477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synoviocyte apoptosis may differentiate responder and non-responder patients to methotrexate treatment in rheumatoid arthritis.
    Lee SY; Park SH; Lee SW; Lee SH; Son MK; Choi YH; Chung WT; Yoo YH
    Arch Pharm Res; 2014 Oct; 37(10):1286-94. PubMed ID: 24988987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of high-molecular-weight sodium hyaluronate on immobilized rabbit knee.
    Sakakibara Y; Miura T; Iwata H; Kikuchi T; Yamaguchi T; Yoshimi T; Itoh H
    Clin Orthop Relat Res; 1994 Feb; (299):282-92. PubMed ID: 8119031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synovial fluid findings in a patient after hylan GF 20 injection.
    Kwan-Morley J; Clayburne G; Schumacher HR
    J Clin Rheumatol; 2008 Apr; 14(2):120. PubMed ID: 18391685
    [No Abstract]   [Full Text] [Related]  

  • 17. Amelioration of disease severity by intraarticular hylan therapy in bilateral canine osteoarthritis.
    Marshall KW; Manolopoulos V; Mancer K; Staples J; Damyanovich A
    J Orthop Res; 2000 May; 18(3):416-25. PubMed ID: 10937628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of different hyaluronic acid products on synovial fluid levels of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in knee osteoarthritis.
    Karatay S; Kiziltunc A; Yildirim K; Karanfil RC; Senel K
    Ann Clin Lab Sci; 2004; 34(3):330-5. PubMed ID: 15487709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyaluronic acid inhibits the expression of u-PA, PAI-1, and u-PAR in human synovial fibroblasts of osteoarthritis and rheumatoid arthritis.
    Nonaka T; Kikuchi H; Ikeda T; Okamoto Y; Hamanishi C; Tanaka S
    J Rheumatol; 2000 Apr; 27(4):997-1004. PubMed ID: 10782829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor efficacy of a novel polymer-peptide-drug conjugate in human tumor xenograft models.
    Chau Y; Padera RF; Dang NM; Langer R
    Int J Cancer; 2006 Mar; 118(6):1519-26. PubMed ID: 16187287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.